글로벌 칸디다증 치료제 시장 - 2028년까지의 산업 동향 및 예측

시장 분석 및 통찰력: 글로벌 칸디다증 치료제 시장

칸디다증 치료제 시장은 2021년에서 2028년까지의 예측 기간 동안 5.10%의 시장 성장을 목격할 것으로 예상됩니다. 칸디다증 치료제 시장에 대한 Data Bridge Market Research 보고서는 예측 기간 내내 만연할 것으로 예상되는 다양한 요인에 대한 분석과 통찰력을 제공하고 시장 성장에 미치는 영향을 제공합니다. 전 세계적으로 질병에 대한 인식이 증가함에 따라 칸디다증 치료제 시장의 성장이 가속화되고 있습니다.

칸디다증은 아구창이라고도 불리며, 모든 연령대의 남성과 여성에게 영향을 미치는 진균 감염을 말합니다. 아구창이 목으로 확장되면 식도염으로 이어집니다. 칸디다증, 모닐리아증, 오이디오미코시스는 칸디다증의 다른 이름 중 일부입니다. 칸디다증은 칸디다 속에 속하는 효모에 의해 발생합니다.

전 세계적으로 칸디다증 감염에 걸린 환자 수의 증가는 칸디다증 치료제 시장 성장을 견인하는 주요 요인 중 하나로 작용합니다. 개발도상국에서 칸디다증과 관련된 감염 및 기타 질병 에 대한 인식이 높아지고 , 미적 외관을 유지하려는 소비자의 성향이 높아짐에 따라 시장 성장이 가속화됩니다. 면역 체계가 약한 취약한 환자 풀의 증가와 제조업체 간의 인수 전략 및 회사 협력의 증가는 시장에 더욱 영향을 미칩니다. 또한 투자 증가, 노령 인구 증가 , 연구 개발 활동 기금 증가, 급속한 도시화는 칸디다증 치료제 시장에 긍정적인 영향을 미칩니다. 나아가 치료제의 발전은 2021년에서 2028년의 예측 기간 동안 시장 참여자에게 수익성 있는 기회를 확대합니다.

On the other hand, availability of alternative treatments such as probiotics and limited research and development activities are expected to obstruct the market growth. Competition from herbal medicines is projected to challenge the candidiasis therapeutics market in the forecast period of 2021-2028.

This candidiasis therapeutics market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info candidiasis therapeutics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth. 

Global Candidiasis Therapeutics Market Scope and Market Size

The candidiasis therapeutics market is segmented on the basis of type, symptom type, treatment type, mode of administration, distribution channel and end user. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

• On the basis of drugs, the candidiasis therapeutics market is segmented into oropharyngeal candidiasis, genital candidiasis, invasive candidasis and others.
• On the basis of symptom type, the candidiasis therapeutics market is segmented into oral thrush, fatigue, urinary tract infection (UTI) and others.
• On the basis of treatment type, the candidiasis therapeutics market is segmented into medication, surgery and others.
• On the basis of mode of administration, the candidiasis therapeutics market is segmented into injectable, oral and others.
• On the basis of distribution channel, the candidiasis therapeutics market is segmented into hospital pharmacies, retail pharmacies and online pharmacies.
• On the basis of end user, the candidiasis therapeutics market is segmented into hospitals, homecare, specialty clinics and others.

Candidiasis Therapeutics Market Country Level Analysis

The candidiasis therapeutics market is analyzed and market size information is provided by country, type, symptom type, treatment type, mode of administration, distribution channel and end user as referenced above.

The countries covered in the candidiasis therapeutics market report are U.S., Canada and Mexico in North America, Peru, Brazil, Argentina and Rest of South America as part of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).

North America dominates the candidiasis therapeutics market due to the higher awareness of the disease amongst individuals and also availability of better treatment within the region. Asia-Pacific is expected to witness high growth during the forecast period of 2021 to 2028 because of the low unmet need in this region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

The candidiasis therapeutics market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analyzed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Candidiasis Therapeutics Market Share Analysis

The candidiasis therapeutics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related candidiasis therapeutics market.

칸디다증 치료제 시장 보고서에 포함된 주요 기업으로는 Bruker, Cidara Therapeutics, Inc., Basilea Pharmaceutica Ltd., Astellas Pharma Inc., Pacgen Life Science Corporation, NovaDigm Therapeutics, Amplyx, NovaBiotics Inc, Bayer AG, Teva Pharmaceutical Industries Ltd., WOCKHARDT, Pfizer Inc., GlaxoSmithKline plc, ALLERGAN, AstraZeneca, Torrent Pharmaceuticals Ltd. 등이 있으며, 국내 및 글로벌 기업도 있습니다. 시장 점유율 데이터는 글로벌, 북미, 유럽, 아시아 태평양(APAC), 중동 및 아프리카(MEA), 남미에 대해 별도로 제공됩니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁자에 대한 경쟁 분석을 별도로 제공합니다.

SKU-47783